JPRN-UMIN000006717
Completed
Phase 4
A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancer - A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancer
Ibaraki respiratory tract tumor study group0 sites200 target enrollmentNovember 15, 2011
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ibaraki respiratory tract tumor study group
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancernon-small-cell lung cancer(Excluding squamous call lung cancer)JPRN-UMIN000007215agasaki thoracic oncology group120
Recruiting
Not Applicable
A clinical study of Bevacizumab therapy in combination with chemotherapeutic drugs for children with recurrent gliomaJPRN-UMIN000005528Osaka University Graduate School of Medicine12
Active, not recruiting
Not Applicable
Bevacizumab+folfiri in untreated patients with advanced colorectal cancer. A phase II multicenter study of the Gruppo Oncologico dell'Italia Meridionale. (GOIM). - Bevacizumab+folfiri in untreated patients with advanced colorectal canceuntreated patients with advanced colorectal cancer.MedDRA version: 9.1Level: LLTClassification code 10010035Term: Colorectal cancer stage IVEUCTR2006-002887-25-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
Recruiting
Phase 3
Clinical Trial of bevacizumab in patients with retinopathy of prematurityretinopathy of prematurityJPRN-jRCT2091220073obuhisa Naoi,MDDepartment of Ophthalmology,School of MedicineUniversity of Miyazaki40
Recruiting
Not Applicable
Phase II study of Bevacizumab in combination with Paclitaxel in metastatic breast cancer patients with asymptomatic brain metastases.Breast CancerJPRN-UMIN000010466Kansai medical university23